BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Murt A. Comparison of parathormone lowering effects of paricalcitol and calcitriol in hemodialysis patients. World J Nephrol 2025; 14(4): 110817 [PMID: 41479833 DOI: 10.5527/wjn.v14.i4.110817]
URL: https://www.wjgnet.com/2220-6124/full/v14/i4/110817.htm
Number Citing Articles
1
Dionysios N. Vrachnis, Maria Apostolopoulou, Rodis D. Paparodis, Eleni Dermitzaki, George Mastorakos, Ioanna N. Grivea, Alexandra Bargiota, Dimitrios T. Papadimitriou. Immunomodulatory Effects of the Calcitriol Analog Paricalcitol. Biomolecules 2026; 16(10) doi: 10.3390/biom16101413
2
Erman Özdemir, Erdoğan Özdemir, Pınar Özdemir. Intravenous Paricalcitol Versus Calcitriol for Secondary Hyperparathyroidism in Maintenance Hemodialysis: A Six-Month Single-Center Retrospective Cohort Study. Journal of Clinical Medicine 2026; 15(14) doi: 10.3390/jcm15145483